Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression

被引：5

作者：

Souza, Sergio A. ^{[1
]}

Josino, Taina R. ^{[1
]}

Bisol, Luisa W. ^{[1
]}

机构：

[1] Univ Hosp Walter Cantidio, Fortaleza, Brazil

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2023年 / 389卷 / 10期

关键词：

ELECTROCONVULSIVE-THERAPY; REMISSION;

D O I：

10.1056/NEJMc2308757

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To the Editor: The article by Anand et al. (June 22 issue)(1) concerns an important issue - the therapeutic approach that should be used for patients with treatment-resistant depression. However, the article has some drawbacks. First, bilateral electroconvulsive therapy (ECT) is standard care for treatment-resistant depression. Bilateral ECT has a faster onset and is more efficacious than unilateral ECT.(2) The patients in this trial who ultimately underwent ECT started with unilateral ECT, which may be an indication that the authors were biased toward the ketamine group. It is awkward that after a median of four sessions, 38.8% of the patients . . .

引用

页码：959 / 962

页数：4

共 50 条

[31] The role of intranasal ketamine in treatment-resistant depression
Costa, M.
Fraga, M.
Moutinho, A.
Cintra, P.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, 53 : S492 - S492
[32] INTRAVENOUS KETAMINE FOR TREATMENT-RESISTANT DEPRESSION IN ADOLESCENTS?
Cullen, Kathryn R.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S284 - S284
[33] Magnesium in Ketamine Administration in Treatment-Resistant Depression
Gorska, Natalia
Cubala, Wieslaw Jerzy
Slupski, Jakub
Wiglusz, Mariusz Stanislaw
Galuszko-Wegielnik, Maria
Kawka, Mateusz
Grzegorzewska, Agata
PHARMACEUTICALS, 2021, 14 (05)
[34] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: A NEW ADVOCATE
Perez-Esparza, Rodrigo
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2018, 70 (02): : 65 - 67
[35] Clinical Efficacy of Ketamine for Treatment-resistant Depression
Bratsos, Sosipatros
Saleh, Sohag N.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
[36] Oral ketamine for the treatment of pain and treatment-resistant depression
Schoevers, Robert A.
Chaves, Tharcila V.
Balukova, Sonya M.
aan het Rot, Marije
Kortekaas, Rudie
BRITISH JOURNAL OF PSYCHIATRY, 2016, 208 (02) : 108 - 113
[37] Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
Salloum, Naji C.
Fava, Maurizio
Freeman, Marlene P.
Flynn, Martina
Hoeppner, Bettina
Hock, Rebecca S.
Cusin, Cristina
Iosifescu, Dan V.
Trivedi, Madhukar H.
Sanacora, Gerard
Mathew, Sanjay J.
Debattista, Charles
Ionescu, Dawn F.
Papakostas, George I.
DEPRESSION AND ANXIETY, 2019, 36 (03) : 235 - 243
[38] Comparison of racemic ketamine and S-ketamine in treatment-resistant major depression: Report of two cases
Paul, Robert
Schaaff, Nadine
Padberg, Frank
Moeller, Hans-Juergen
Frodl, Thomas
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (03): : 241 - 244
[39] Serum BDNF as a peripheral biomarker of treatment-resistant depression and the rapid antidepressant response: A comparison of ketamine and ECT
Allen, A. P.
Naughton, M.
Dowling, J.
Walsh, A.
Ismail, F.
Shorten, G.
Scott, L.
McLoughlin, D. M.
Cryan, J. F.
Dinan, T. G.
Clarke, G.
JOURNAL OF AFFECTIVE DISORDERS, 2015, 186 : 306 - 311
[40] Managing treatment-resistant major depression
Nelson, JC
JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 : 5 - 12

← 1 2 3 4 5 →